Enhancement of bioavailability by use of focused energy delivery to a target tissue
US6066123A · kind A · utility
84Cited by
11References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1998 |
| Grant date | May 23, 2000 |
| Priority date | — |
| Expiry date | Apr 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2090/374
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Targeted tissue in vivo is altered using focused energy to specifically control endothelial permeability and interstitial integrity. Image guidance may be used in combination with physical energy deposition to facilitate the targeted delivery of materials. The method of the invention serves as a platform for delivering pharmaceutical agents, nucleic acids, proteins, liposomes, etc. to cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.